Copyright Reports & Markets. All rights reserved.

Global Hemato Oncology Testing Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hemato Oncology Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 ctDNA Testing
    • 1.2.3 CTC Testing
    • 1.2.4 Other Testing
  • 1.3 Market by Application
    • 1.3.1 Global Hemato Oncology Testing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Third Party Agency
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hemato Oncology Testing Market Perspective (2016-2027)
  • 2.2 Hemato Oncology Testing Growth Trends by Regions
    • 2.2.1 Hemato Oncology Testing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Hemato Oncology Testing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Hemato Oncology Testing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Hemato Oncology Testing Industry Dynamic
    • 2.3.1 Hemato Oncology Testing Market Trends
    • 2.3.2 Hemato Oncology Testing Market Drivers
    • 2.3.3 Hemato Oncology Testing Market Challenges
    • 2.3.4 Hemato Oncology Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hemato Oncology Testing Players by Revenue
    • 3.1.1 Global Top Hemato Oncology Testing Players by Revenue (2016-2021)
    • 3.1.2 Global Hemato Oncology Testing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Hemato Oncology Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hemato Oncology Testing Revenue
  • 3.4 Global Hemato Oncology Testing Market Concentration Ratio
    • 3.4.1 Global Hemato Oncology Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hemato Oncology Testing Revenue in 2020
  • 3.5 Hemato Oncology Testing Key Players Head office and Area Served
  • 3.6 Key Players Hemato Oncology Testing Product Solution and Service
  • 3.7 Date of Enter into Hemato Oncology Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hemato Oncology Testing Breakdown Data by Type

  • 4.1 Global Hemato Oncology Testing Historic Market Size by Type (2016-2021)
  • 4.2 Global Hemato Oncology Testing Forecasted Market Size by Type (2022-2027)

5 Hemato Oncology Testing Breakdown Data by Application

  • 5.1 Global Hemato Oncology Testing Historic Market Size by Application (2016-2021)
  • 5.2 Global Hemato Oncology Testing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Hemato Oncology Testing Market Size (2016-2027)
  • 6.2 North America Hemato Oncology Testing Market Size by Type
    • 6.2.1 North America Hemato Oncology Testing Market Size by Type (2016-2021)
    • 6.2.2 North America Hemato Oncology Testing Market Size by Type (2022-2027)
    • 6.2.3 North America Hemato Oncology Testing Market Size by Type (2016-2027)
  • 6.3 North America Hemato Oncology Testing Market Size by Application
    • 6.3.1 North America Hemato Oncology Testing Market Size by Application (2016-2021)
    • 6.3.2 North America Hemato Oncology Testing Market Size by Application (2022-2027)
    • 6.3.3 North America Hemato Oncology Testing Market Size by Application (2016-2027)
  • 6.4 North America Hemato Oncology Testing Market Size by Country
    • 6.4.1 North America Hemato Oncology Testing Market Size by Country (2016-2021)
    • 6.4.2 North America Hemato Oncology Testing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Hemato Oncology Testing Market Size (2016-2027)
  • 7.2 Europe Hemato Oncology Testing Market Size by Type
    • 7.2.1 Europe Hemato Oncology Testing Market Size by Type (2016-2021)
    • 7.2.2 Europe Hemato Oncology Testing Market Size by Type (2022-2027)
    • 7.2.3 Europe Hemato Oncology Testing Market Size by Type (2016-2027)
  • 7.3 Europe Hemato Oncology Testing Market Size by Application
    • 7.3.1 Europe Hemato Oncology Testing Market Size by Application (2016-2021)
    • 7.3.2 Europe Hemato Oncology Testing Market Size by Application (2022-2027)
    • 7.3.3 Europe Hemato Oncology Testing Market Size by Application (2016-2027)
  • 7.4 Europe Hemato Oncology Testing Market Size by Country
    • 7.4.1 Europe Hemato Oncology Testing Market Size by Country (2016-2021)
    • 7.4.2 Europe Hemato Oncology Testing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Hemato Oncology Testing Market Size (2016-2027)
  • 8.2 Asia-Pacific Hemato Oncology Testing Market Size by Type
    • 8.2.1 Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Hemato Oncology Testing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Hemato Oncology Testing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Hemato Oncology Testing Market Size by Application
    • 8.3.1 Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Hemato Oncology Testing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Hemato Oncology Testing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Hemato Oncology Testing Market Size by Region
    • 8.4.1 Asia-Pacific Hemato Oncology Testing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Hemato Oncology Testing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Hemato Oncology Testing Market Size (2016-2027)
  • 9.2 Latin America Hemato Oncology Testing Market Size by Type
    • 9.2.1 Latin America Hemato Oncology Testing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Hemato Oncology Testing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Hemato Oncology Testing Market Size by Type (2016-2027)
  • 9.3 Latin America Hemato Oncology Testing Market Size by Application
    • 9.3.1 Latin America Hemato Oncology Testing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Hemato Oncology Testing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Hemato Oncology Testing Market Size by Application (2016-2027)
  • 9.4 Latin America Hemato Oncology Testing Market Size by Country
    • 9.4.1 Latin America Hemato Oncology Testing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Hemato Oncology Testing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Hemato Oncology Testing Market Size (2016-2027)
  • 10.2 Middle East & Africa Hemato Oncology Testing Market Size by Type
    • 10.2.1 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Hemato Oncology Testing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Hemato Oncology Testing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Hemato Oncology Testing Market Size by Application
    • 10.3.1 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Hemato Oncology Testing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Hemato Oncology Testing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Hemato Oncology Testing Market Size by Country
    • 10.4.1 Middle East & Africa Hemato Oncology Testing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Hemato Oncology Testing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Roche
    • 11.1.1 Roche Company Details
    • 11.1.2 Roche Business Overview
    • 11.1.3 Roche Hemato Oncology Testing Introduction
    • 11.1.4 Roche Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.1.5 Roche Recent Development
  • 11.2 Berry Genomics
    • 11.2.1 Berry Genomics Company Details
    • 11.2.2 Berry Genomics Business Overview
    • 11.2.3 Berry Genomics Hemato Oncology Testing Introduction
    • 11.2.4 Berry Genomics Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.2.5 Berry Genomics Recent Development
  • 11.3 Burning Rock Dx
    • 11.3.1 Burning Rock Dx Company Details
    • 11.3.2 Burning Rock Dx Business Overview
    • 11.3.3 Burning Rock Dx Hemato Oncology Testing Introduction
    • 11.3.4 Burning Rock Dx Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.3.5 Burning Rock Dx Recent Development
  • 11.4 BGI
    • 11.4.1 BGI Company Details
    • 11.4.2 BGI Business Overview
    • 11.4.3 BGI Hemato Oncology Testing Introduction
    • 11.4.4 BGI Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.4.5 BGI Recent Development
  • 11.5 Genetron
    • 11.5.1 Genetron Company Details
    • 11.5.2 Genetron Business Overview
    • 11.5.3 Genetron Hemato Oncology Testing Introduction
    • 11.5.4 Genetron Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.5.5 Genetron Recent Development
  • 11.6 Haplox
    • 11.6.1 Haplox Company Details
    • 11.6.2 Haplox Business Overview
    • 11.6.3 Haplox Hemato Oncology Testing Introduction
    • 11.6.4 Haplox Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.6.5 Haplox Recent Development
  • 11.7 Amoy Dx
    • 11.7.1 Amoy Dx Company Details
    • 11.7.2 Amoy Dx Business Overview
    • 11.7.3 Amoy Dx Hemato Oncology Testing Introduction
    • 11.7.4 Amoy Dx Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.7.5 Amoy Dx Recent Development
  • 11.8 Genosaber
    • 11.8.1 Genosaber Company Details
    • 11.8.2 Genosaber Business Overview
    • 11.8.3 Genosaber Hemato Oncology Testing Introduction
    • 11.8.4 Genosaber Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.8.5 Genosaber Recent Development
  • 11.9 YZY Biopharma
    • 11.9.1 YZY Biopharma Company Details
    • 11.9.2 YZY Biopharma Business Overview
    • 11.9.3 YZY Biopharma Hemato Oncology Testing Introduction
    • 11.9.4 YZY Biopharma Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.9.5 YZY Biopharma Recent Development
  • 11.10 Wondfo
    • 11.10.1 Wondfo Company Details
    • 11.10.2 Wondfo Business Overview
    • 11.10.3 Wondfo Hemato Oncology Testing Introduction
    • 11.10.4 Wondfo Revenue in Hemato Oncology Testing Business (2016-2021)
    • 11.10.5 Wondfo Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hemato Oncology Testing Scope and Market Size
    Hemato Oncology Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hemato Oncology Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    ctDNA Testing
    CTC Testing
    Other Testing

    Segment by Application
    Hospital
    Third Party Agency
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Roche
    Berry Genomics
    Burning Rock Dx
    BGI
    Genetron
    Haplox
    Amoy Dx
    Genosaber
    YZY Biopharma
    Wondfo

    Buy now